← Leaderboards
Thomas G Burke
University Of Maryland Baltimore
$1,743,761
Attributed
$1,743,761
Total exposure
8
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,743,761 · 8
By mechanism
P41$653,717 · 3
R01$572,919 · 2
R42$284,000 · 1
R41$233,125 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Joseph R. Lakowicz$15,967,328
- Russell J Digate$1,517,339
- Alessio Fasano$18,889,816
- Huang Chiao Huang$6,185,360
- Jeffrey A Winkles$6,417,695
Others in their field
Top investigators on “Biomedical Resource”
- Eric S Lander · Whitehead Institute For Biomedical Res$327,348,429
- Richard A Gibbs · Baylor College Of Medicine$197,881,494
- Julianne L Imperato-McGinley · Weill Medical College Of Cornell Univ$159,861,320
- Ronald J Sokol · University Of Colorado Denver$154,805,139
- Steven M. Dubinett · Va Greater Los Angeles Healthcare System$154,215,387
- Joseph E Robertson · Oregon Health & Science University$128,745,682
Research focus
Biomedical ResourceCamptothecinInformaticsBiological ProductsDna TopoisomerasesEnzyme InhibitorsSpectrometryDrug Design /Synthesis /ProductionBiomedical Equipment DevelopmentHuman TissueLiposomesLaboratory MouseNeoplasm /CancerChemical SynthesisCombinatorial ChemistryLactonesAthymic MousePharmacokineticsAnalogAntineoplasticsProdrugsSerumAffinity ChromatographyTissue /Cell Culture
Grant awards (10)
PREFERENTIAL BINDING OF CARBOXYLATE FORM OF CAMTOTHECIN BY HUMAN SERUM ALBUMIN$10,991
P41 · FY2004 · RR
Combinatorial Development of Blood Stable Camptothecins$319,163
R01 · FY2001 · CA
FLUORESCENCE DETECTION OF ANTI CANCER DRUG TOPOTECAN$293,069
P41 · FY2001 · RR
PREFERENTIAL BINDING OF CARBOXYLATE FORM OF CAMTOTHECIN BY HUMAN SERUM ALBUMIN$293,069
P41 · FY2001 · RR
Long Circulating Liposomal Camptothecins CAP and EAP$284,000
R42 · FY2001 · CA
Potent Topoisomerase I Inhibition For Glioma Therapy$133,125
R41 · FY2001 · CA
LONG-CIRCULATING LIPOSOMAL CAMPTOTHECINS$253,756
R01 · FY2000 · CA
COMBINATORIAL DEVELOPMENT OF ANTICANCER SILATECANS$100,000
R41 · FY2000 · CA
FLUORESCENCE DETECTION OF ANTI CANCER DRUG TOPOTECAN$28,294
P41 · FY2000 · RR
PREFERENTIAL BINDING OF CARBOXYLATE FORM OF CAMTOTHECIN BY HUMAN SERUM ALBUMIN$28,294
P41 · FY2000 · RR